产品详情 |
Edit |   |
Antigenic Specificity | Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (aa 1-331) |
Clone | S84-37 |
Host Species | Mouse |
Reactive Species | human |
Isotype | n/a |
Format | allophycocyanin (APC) conjugate |
Size | 100 µg |
Concentration | n/a |
Applications | Immunocytochemistry (ICC),Immunofluorescence (IF),Western Blotting (WB) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Laforin, also known as Lafora PTPase, is a dual specificity protein phosphatase. Laforin is involved in the control of glycogen metabolism, specifically in preventing the formation of poorly branched glycogen molecules (polyglucosans). Laforin forms a complex with NHLRC1/malin and HSP70 that suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). Laforin is expressed in heart, skeletal muscle, kidney, pancreas and brain. Defective Laforin is linked to progressive myoclonic epilepsy type 2 (EPM2).Cellular Localization: Endoplasmic reticulum |
Immunogen | Fusion protein amino acids 1-331 (full-length) of human Laforin. Rat: 90% identity (296/327 amino acids identical). Mouse: 89% identity (295/327 amino acids identical) |
Other Names | TG-B|Tg(TcraK,TcrbK)TG-BFlv|EPM2|MELF|laforin |
Gene, Accession # | Gene ID: 7957 |
Catalog # | ABIN1741369 |
Price | |
Order / More Info | Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (aa 1-331) Antibody from ANTIBODIES-ONLINE GmbH |
Product Specific References | n/a |
产品资料 |
|
|